Results 21 to 30 of about 2,976 (190)

Clinicopathologic study of triple-negative breast cancer with special reference to basal-like breast cancer phenotype in a tertiary care hospital of Eastern India

open access: yesAsian Journal of Medical Sciences, 2023
Background: Triple-negative breast cancer (TNBC) is defined as absent expression of estrogen receptor (ER) and progesterone receptors and human epidermal growth factor receptors (HER2neu). These cancers are associated with poor prognosis.
Rajashree Pradhan   +3 more
doaj   +1 more source

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival [PDF]

open access: yes, 2017
Purpose: In contrast to other countries, the Dutch breast cancer guideline does not recommend re-excision for focally positive margins after breast-conserving surgery (BCS) in invasive tumor and does recommend whole-breast irradiation including boost. We
Baaijens, M. (Margreet)   +6 more
core   +3 more sources

Immunohistochemical Expression of Her2neu in Premalignant and Malignant Lesion of Gall Bladder

open access: yesScholars Journal of Applied Medical Sciences, 2022
Purpose: To evaluate the expression of Her2-neu in benign and malignant gallbladder lesions, and to establish correlations with clinico-pathologic parameters. Materials and Methods: Retrospective and prospective analysis was conducted on formalin fixed paraffin embedded (FFPE) 154 tissue sample included Premaligant and premalignant like lesions ...
Ajay Kr .Singh   +3 more
openaire   +1 more source

Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience

open access: yesOpen Heart, 2021
Objective Antimicrotubular agents are among the most commonly used classes of chemotherapeutic agents, but the risk of cardiovascular adverse events (CVAEs) remains unclear.
Avirup Guha   +14 more
doaj   +1 more source

Perioperative therapy with FLOT4 significantly increases survival in patients with gastroesophageal and gastric cancer in a large real‐world cohort

open access: yesInternational Journal of Cancer, Volume 153, Issue 3, Page 609-622, 1 August 2023., 2023
What's New In 2019, the FLOT‐4 trial established the new perioperative chemotherapy standard for patients with locally advanced gastroesophageal and gastric cancer. To date, post‐approval data remain scarce. This retrospective study verifies the real‐world efficacy of the FLOT4 protocol in the perioperative setting and demonstrates a significant ...
Christian Möhring   +17 more
wiley   +1 more source

FIGO staging of endometrial cancer: 2023

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 162, Issue 2, Page 383-394, August 2023., 2023
Abstract Introduction Many advances in the understanding of the pathologic and molecular features of endometrial cancer have occurred since the FIGO staging was last updated in 2009. Substantially more outcome and biological behavior data are now available regarding the several histological types.
Jonathan S. Berek   +36 more
wiley   +1 more source

Preoperative Hormone Therapy in the Treatment of Breast Cancer: What Do We Know So Far?

open access: yesКреативная хирургия и онкология, 2022
Breast cancer is the most common malignant disease in the world. One of the methods of treating breast cancer is neoadjuvant chemotherapy. Neoadjuvant chemotherapy (NCT) is now the standard of care for locally advanced breast cancer.
V. V. Vorotnikov   +6 more
doaj   +1 more source

Clinical-pathological features of an occult mixed mucinous male breast cancer. a case report [PDF]

open access: yes, 2017
Mucinous carcinoma of the male breast is an uncommon malignant breast neoplasm and its diagnoses remain difficult. It is probably due to such a low rate of breast cancer cases that men tend to be diagnosed at an older age than women and with a later ...
Bonifacino, Adriana   +7 more
core   +1 more source

Same day estrogen, progesterone and HER2neu receptor assessment in breast cancer diagnosis using Core Wash Cytology

open access: yesSurgical Oncology, 2023
01 april ...
R.C. van den Oudenalder   +4 more
openaire   +4 more sources

Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review

open access: yesCancer Reports, Volume 6, Issue 5, May 2023., 2023
Abstract Background Squamous cell carcinoma (SCC) is a relatively common and heterogenous malignancy of different organs, such as the skin, esophagus, and lungs. Although most cases experience good survival with surgical methods, management of advanced types of the disease remains challenging.
Amirhossein Tamimi   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy